XNK Therapeutics: Funding, Investors & Team (Sep 2026)
XNK Therapeutics is an immunotherapy company in the clinical stage that aims to prevent and treat cancer through the creation of innovative therapies using NK cells. The company is a leader in developing and manufacturing autologous NK cell-based products using its unique technology platform. This platform and the company's investigational drug candidate have advantageous qualities for targeting cancer, particularly in situations where allogeneic cell products are not suitable. It is expected that this product will play a crucial role in future cancer treatment strategies. XNK Therapeutics is based in Stockholm, Sweden.
XNK Therapeutics has raised $14.2M across 3 funding rounds on record, the most recent an undisclosed round of $160k announced in Oct 2023.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
XNK Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2023.
XNK Therapeutics Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
XNK Therapeutics raised $14.0M in an undisclosed round announced in Mar 2022.
1.3 years later, an undisclosed round was announced in Jul 2023 with no disclosed amount.
3 months later, an undisclosed round of $160k was announced in Oct 2023.
XNK Therapeutics Founders and Leadership Team
Contact details for the XNK Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →XNK Therapeutics Funding Compared to Other Health Care Startups
XNK Therapeutics' latest round of $160k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like XNK Therapeutics in Health Care and Huddinge
Companies Similar to XNK Therapeutics
Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have…
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the…
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and…
Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…
B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…
Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company…
Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…
XNK Therapeutics Funding FAQs
What does XNK Therapeutics do?
XNK Therapeutics is an immunotherapy company in the clinical stage that aims to prevent and treat cancer through the creation of innovative therapies using NK cells. The company is a leader in developing and manufacturing autologous NK cell-based products using its unique technology platform. This platform and the company's investigational drug candidate have advantageous qualities for targeting cancer, particularly in situations where allogeneic cell products are not suitable. It is expected that this product will play a crucial role in future cancer treatment strategies. XNK Therapeutics is based in Stockholm, Sweden.
How much funding has XNK Therapeutics raised?
XNK Therapeutics has raised $14.2M across 3 rounds on record. The most recent is an undisclosed round of $160k announced in Oct 2023.
When did XNK Therapeutics last raise funding?
XNK Therapeutics' most recent funding round on record is an undisclosed round of $160k, announced in Oct 2023.
Who is the CEO of XNK Therapeutics?
Johan Liwing is listed as CEO at XNK Therapeutics.
Where is XNK Therapeutics headquartered?
XNK Therapeutics is based in Huddinge, Stockholms Lan, Sweden.
How many employees does XNK Therapeutics have?
XNK Therapeutics is in the 11-50 employee band.
How does XNK Therapeutics' funding compare to other Health Care startups?
XNK Therapeutics' latest round of $160k is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's XNK Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for XNK Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.